NETTER-1 Phase III Trial: Recent Findings on Quality of Life in Patients with Midgut Neuroendocrine TumorsShow others and affiliations
2017 (English)In: Neuroendocrinology, ISSN 0028-3835, E-ISSN 1423-0194, Vol. 105, p. 257-257Article in journal, Meeting abstract (Other academic) Published
Place, publisher, year, edition, pages
KARGER , 2017. Vol. 105, p. 257-257
Keywords [en]
177lu-dotatate, prrt, net, quality of life
National Category
Cancer and Oncology
Identifiers
URN: urn:nbn:se:uu:diva-346592ISI: 000413957900258OAI: oai:DiVA.org:uu-346592DiVA, id: diva2:1191814
Conference
14th Annual ENETS Conference for the Diagnosis and Treatment of Neuroendocrine Tumor Disease, MAR 08-10, 2017, Barcelona, SPAIN
2018-03-202018-03-202018-03-20Bibliographically approved